About
Next-Generation Therapies for Major Neuropsychiatric Disorders
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (22)
Charles Dunn
SV Health Investors
Draig Therapeutics
team_member
Charles Large
Founder and CEO
Draig Therapeutics
executivefounder
Charlotte Allerton
Head of Early R&D
Draig Therapeutics
team_member
Colleen Cuffaro
Canaan Partners
Draig Therapeutics
team_member
David Watson
Chief Operating Officer
Draig Therapeutics
executive
Douglas Williams
Independent
Draig Therapeutics
team_member
Locations (1)
Headquarters
Cardiff, UK
Map
Loading map...